When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYCC - Cyclacel up 38% premarket on COVID-19 plan in UK
Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals (NASDAQ:CYCC) has entered into an agreement with the University of Edinburgh to study fadraciclib (CYC065) and seliciclib (CYC202 or R-roscovitine), its clinical-stage CDK2/9 inhibitors, as early treatments for the inflammatory response observed in patients with COVID-19 disease.
More news on: Cyclacel Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,